Plain-English translation of NCT06783309 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 1 Diabetes Mellitus research guide →Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This clinical trial is testing an investigational medication called to see if it can help people with recently diagnosed type 1 diabetes. The study will measure whether the medication is safe, how well it is tolerated, and whether it can help preserve the body's remaining ability to produce insulin. Researchers will give participants three IV infusions of the medication over 3 months, then follow them for several months afterward to see what happens.
Type 1 diabetes is an autoimmune disease where the body attacks the cells that make insulin. If caught early, there may be a window of opportunity to slow down this attack and preserve some of the body's remaining insulin-producing ability. This medication is being tested to see if it can help during this early stage of the disease.
You likely qualify if…
You likely don't qualify if…
You would come to the clinic for screening visits over about 4 weeks, then receive three IV infusions of the medication on specific days during a 3-month treatment period. After that, you would return for follow-up visits over the next several months (through about day 365 of the study) so doctors can monitor how you are doing. Throughout the study, you will continue taking insulin as usual and have blood tests to check your diabetes and how your body is responding to the medication.
AI-generated summary from trial data · Sep 20, 2026 · Not medical advice
United States